Senators reach $10 billion Covid funding deal for therapeutics, vaccines and testing

Senators reach  billion Covid funding deal for therapeutics, vaccines and testing


U.S. Senator Mitt Romney (R-UT) speaks during a Senate Health, Education, Labor, and Pensions Committee hearing to examine the federal response to the coronavirus disease (COVID-19) and new emerging variants at Capitol Hill in Washington, D.C., January 11, 2022.

Greg Nash | Pool | Reuters

Senate Republicans and Democrats reached a deal Monday on $10 billion in additional Covid funding to buy therapeutics and vaccines and maintain the nation’s testing capacity if another Covid wave hits the U.S.

The legislation earmarks at least $5 billion to purchase and develop Covid treatments such as antiviral pills. Another $750 million is set aside to develop vaccines that target specific variants and to expand vaccine manufacturing capacity in the U.S. if needed.

The funding is less than half the $22.5 billion that President Joe Biden first requested. The deal does not include money to support the administration’s efforts to increase vaccinations around the world.

White House press secretary Jen Psaki said every dollar the administration requested is essential, and noted that the White House will work to get Congress to pass more aid. However, Psaki said time is of the essence, and urged lawmakers to swiftly pass the $10 billion.

“We urge Congress to move promptly on this $10 billion package because it can begin to fund the most immediate needs, as we currently run the risk of not having some critical tools like treatments and tests starting in May and June,” Psaki said.

Congress has fumbled Covid funding as the White House warned that the U.S. would not have enough money to ensure all Americans have access to vaccines in the fall without new aid. House Democrats originally sought to pass $15 billion in Covid funding last month, but Republicans insisted on redirecting money already appropriated for state and local governments to cover any new spending. Negotiations moved to the Senate after the House failed to reach a bipartisan agreement.

Sen. Mitt Romney, R-Utah, said the $10 billion is fully paid for by repurposing unspent Covid funds from the Agriculture, Education, Treasury and Transportation Departments as well as the Small Business Administration.

Senate Majority Leader Chuck Schumer, D-N.Y., said he was disappointed the legislation does not include money to support the Biden administration’s efforts to increase vaccinations around the world. Schumer said the initiative is crucial to prevent the emergence of a breakthrough Covid variant that can evade the protection provided by the current shots.

Schumer and Romney said they were willing to work together on a supplemental international Covid aid package later this spring.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Tom Brady, famed health nut, explains his junk food endorsements in retirement: ‘Moderation in all things’
Business

Tom Brady, famed health nut, explains his junk food endorsements in retirement: ‘Moderation in all things’

From Pizza Hut to Dunkin’, Tom Brady is seemingly everywhere these days promoting food brands he once wouldn’t have touched during his NFL playing days. The seven-time Super Bowl winning quarterback famously followed a strict health-focused diet and once referred to soda and sugary cereals as “poison for kids.” But Brady says he’s softened his […]

Read More
Mercedes U.S. CEO sets ambitious sales goal despite ‘tougher’ market than anticipated
Business

Mercedes U.S. CEO sets ambitious sales goal despite ‘tougher’ market than anticipated

Mercedes-Benz USA CEO Adam Chamberlain said Tuesday that 2026 is shaping up to be more challenging than expected.   “If you look at the market in the first couple of months of the year, the market environment is definitely a little tougher than we anticipated,” Chamberlain told CNBC at the company’s manufacturing plant in Vance, […]

Read More
Nike is set to report earnings after the bell. Here’s what Wall Street expects
Business

Nike is set to report earnings after the bell. Here’s what Wall Street expects

A Nike logo is displayed at a Nike store on Feb. 5, 2026 in Austin, Texas. Brandon Bell | Getty Images Nike is expected to report a steep decline in quarterly profit and flat sales on Tuesday as the sneaker giant continues to work through a colossal turnaround under CEO Elliott Hill.  About a year […]

Read More